These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19810163)

  • 1. [The inhibition of the Sonic Hedgehog (SHh) pathway improves the effects of chemotherapy in a model of ductal carcinoma of the pancreas in mice].
    Larsen CJ
    Bull Cancer; 2009 Sep; 96(9):829. PubMed ID: 19810163
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer. Breaching the cancer fortress.
    Olson P; Hanahan D
    Science; 2009 Jun; 324(5933):1400-1. PubMed ID: 19520948
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.
    Olive KP; Jacobetz MA; Davidson CJ; Gopinathan A; McIntyre D; Honess D; Madhu B; Goldgraben MA; Caldwell ME; Allard D; Frese KK; Denicola G; Feig C; Combs C; Winter SP; Ireland-Zecchini H; Reichelt S; Howat WJ; Chang A; Dhara M; Wang L; Rückert F; Grützmann R; Pilarsky C; Izeradjene K; Hingorani SR; Huang P; Davies SE; Plunkett W; Egorin M; Hruban RH; Whitebread N; McGovern K; Adams J; Iacobuzio-Donahue C; Griffiths J; Tuveson DA
    Science; 2009 Jun; 324(5933):1457-61. PubMed ID: 19460966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine resistance in pancreatic cancer: picking the key players.
    Kim MP; Gallick GE
    Clin Cancer Res; 2008 Mar; 14(5):1284-5. PubMed ID: 18316544
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclopamine reverts acquired chemoresistance and down-regulates cancer stem cell markers in pancreatic cancer cell lines.
    Yao J; An Y; Wie JS; Ji ZL; Lu ZP; Wu JL; Jiang KR; Chen P; Xu ZK; Miao Y
    Swiss Med Wkly; 2011; 141():w13208. PubMed ID: 21630164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport properties of pancreatic cancer describe gemcitabine delivery and response.
    Koay EJ; Truty MJ; Cristini V; Thomas RM; Chen R; Chatterjee D; Kang Y; Bhosale PR; Tamm EP; Crane CH; Javle M; Katz MH; Gottumukkala VN; Rozner MA; Shen H; Lee JE; Wang H; Chen Y; Plunkett W; Abbruzzese JL; Wolff RA; Varadhachary GR; Ferrari M; Fleming JB
    J Clin Invest; 2014 Apr; 124(4):1525-36. PubMed ID: 24614108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer.
    Hessmann E; Patzak MS; Klein L; Chen N; Kari V; Ramu I; Bapiro TE; Frese KK; Gopinathan A; Richards FM; Jodrell DI; Verbeke C; Li X; Heuchel R; Löhr JM; Johnsen SA; Gress TM; Ellenrieder V; Neesse A
    Gut; 2018 Mar; 67(3):497-507. PubMed ID: 28077438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-targeting of CXCR4 and hedgehog pathways disrupts tumor-stromal crosstalk and improves chemotherapeutic efficacy in pancreatic cancer.
    Khan MA; Srivastava SK; Zubair H; Patel GK; Arora S; Khushman M; Carter JE; Gorman GS; Singh S; Singh AP
    J Biol Chem; 2020 Jun; 295(25):8413-8424. PubMed ID: 32358063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hedgehog inhibitor decreases chemosensitivity to 5-fluorouracil and gemcitabine under hypoxic conditions in pancreatic cancer.
    Onishi H; Morifuji Y; Kai M; Suyama K; Iwasaki H; Katano M
    Cancer Sci; 2012 Jul; 103(7):1272-9. PubMed ID: 22486854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer.
    Feldmann G; Habbe N; Dhara S; Bisht S; Alvarez H; Fendrich V; Beaty R; Mullendore M; Karikari C; Bardeesy N; Ouellette MM; Yu W; Maitra A
    Gut; 2008 Oct; 57(10):1420-30. PubMed ID: 18515410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of gemcitabine sensitivity and protein kinase B signaling in pancreatic ductal adenocarcinoma models.
    Pham NA; Tsao MS; Cao P; Hedley DW
    Pancreas; 2007 Oct; 35(3):e16-26. PubMed ID: 17895832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear expression of glioma-associated oncogene homolog 1 and nuclear factor-κB is associated with a poor prognosis of pancreatic cancer.
    Yang SH; Hsu CH; Lee JC; Tien YW; Kuo SH; Cheng AL
    Oncology; 2013; 85(2):86-94. PubMed ID: 23860225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ASO Author Reflections: Regulation of Chemoresistance in Pancreatic Ductal Adenocarcinoma by Scavenger Receptor CD36.
    Kubo M; Eguchi H
    Ann Surg Oncol; 2020 Feb; 27(2):620-621. PubMed ID: 31659646
    [No Abstract]   [Full Text] [Related]  

  • 14. [Modern possibilities of chemotherapy in patients with ductal pancreatic adenocarcinoma].
    Kopchak VM; Kopchak KV; Romaniv IaV
    Klin Khir; 2006 Feb; (2):23-5. PubMed ID: 16826811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRD4 promotes pancreatic ductal adenocarcinoma cell proliferation and enhances gemcitabine resistance.
    Wang YH; Sui YN; Yan K; Wang LS; Wang F; Zhou JH
    Oncol Rep; 2015 Apr; 33(4):1699-706. PubMed ID: 25647019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemcitabine-induced pulmonary toxicity in a patient with pancreatic cancer.
    Hiraya D; Kagohashi K; Sakamoto N; Kondo T; Satoh H
    JOP; 2010 Mar; 11(2):186-8. PubMed ID: 20208333
    [No Abstract]   [Full Text] [Related]  

  • 17. [New perspectives for radiosensitization in pancreatic carcinoma: a review of mechanisms involved in pancreatic tumorigenesis].
    Huguet F; Fernet M; Monnier L; Touboul E; Favaudon V
    Cancer Radiother; 2011 Aug; 15(5):365-75. PubMed ID: 21664851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin inhibits sonic hedgehog signaling and stemness features of pancreatic cancer.
    Yin Y; Liu L; Zhao Z; Yin L; Bauer N; Nwaeburu CC; Gladkich J; Gross W; Hackert T; Sticht C; Gretz N; Strobel O; Herr I
    Cancer Lett; 2018 Jul; 426():14-24. PubMed ID: 29627496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging monitors physiological changes with antihedgehog therapy in pancreatic adenocarcinoma xenograft model.
    Guimaraes AR; Rakhlin E; Weissleder R; Thayer SP
    Pancreas; 2008 Nov; 37(4):440-4. PubMed ID: 18953259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hedgehog pathway and pancreatic cancer.
    Hidalgo M; Maitra A
    N Engl J Med; 2009 Nov; 361(21):2094-6. PubMed ID: 19923581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.